1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc.

INBS
Intelligent Bio Solutions Inc.US flagNASDAQ Capital Market
2.23
USD
-0.07
- -
1.44MMarket Cap

Total Valuation

Intelligent Bio Solutions Inc. carries a market capitalization of 1.44M, placing it among publicly traded companies globally. Its enterprise value stands at 4.29M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap1.44M
Enterprise Value4.29M

Share Statistics

Intelligent Bio Solutions Inc. currently has 2.91M shares outstanding.

Shares Outstanding2.91M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 0.62, and the price-to-book ratio stands at 1.21.

PE RatioN/A
PS Ratio0.62
PB Ratio1.21
P/TBV Ratio2.46
P/FCF Ratio-0.22
P/OCF Ratio-0.22

Enterprise Valuation

EV / Sales1.02
EV / EBITDAN/A
EV / EBITN/A
EV / FCFN/A

Financial Position

Intelligent Bio Solutions Inc. maintains a current ratio of 1.44, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 34.38, indicating elevated leverage, while an interest coverage ratio of -163.90 demonstrates limited ability to service its debt obligations.

Current Ratio1.44
Quick Ratio1.15
Debt / Equity34.38
Debt / EBITDA-0.16
Interest Coverage-163.90

Financial Efficiency

Return on Equity (ROE)-292.25
Return on Assets (ROA)-123.13
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover4.11

Stock Price Statistics

Intelligent Bio Solutions Inc.'s stock has declined approximately -86.44377% over the past 52 weeks. The 50-day moving average sits at 2.21, while the 200-day moving average is 4.40.

Beta (5Y)N/A
52-Week Price Change-86.44377%
50-Day Moving Average2.21
200-Day Moving Average4.40
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Intelligent Bio Solutions Inc. generated 4.22M in revenue and converted that into -12.43M in net income, yielding earnings per share of -11.00. EBITDA reached -11.09M, while operating income came in at -12.25M.

Revenue4.22M
Gross Profit2.05M
Operating Income-12.25M
Pretax Income-12.47M
Net Income-12.43M
EBITDA-11.09M
EBIT-12.25M
Earnings Per Share (EPS)-11.00

Balance Sheet

Intelligent Bio Solutions Inc. holds 3.99M in cash and equivalents against 1.82M in total debt, resulting in a net debt position of -3.99M. Total book value stands at 5.51M, with working capital of 2.17M providing operational flexibility.

Cash & Cash Equivalents3.99M
Total Debt1.82M
Net Debt-3.99M
Equity (Book Value)5.51M
Book Value Per Share1.90
Working Capital2.17M

Cash Flow

Intelligent Bio Solutions Inc. produced -11.93M in operating cash flow over the past twelve months. After subtracting -125,731.00 in capital expenditures, free cash flow totaled -12.05M - equivalent to -10.63 per share.

Operating Cash Flow-11.93M
Capital Expenditures-125,731.00
Free Cash Flow-12.05M
FCF Per Share-10.63

Margins

Intelligent Bio Solutions Inc. operates with a gross margin of 48.63, reflecting its pricing power and cost economics. The operating margin of -290.68 and net profit margin of -294.91 provide insight into operational efficiency.

Gross Margin48.63
Operating Margin-290.68
Pretax Margin-295.80
Profit Margin-294.91
EBITDA Margin-263.07

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield-224.21
FCF Yield-452.74

Stock Splits

Intelligent Bio Solutions Inc.'s most recent stock split took place on December 16, 2025 with a 10:1 split ratio.

Last Split Date12/16/2025
Split Ratio10:1

Scores

Intelligent Bio Solutions Inc. posts an Altman Z-Score of -14.55, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-14.55